In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
Increase in incidence of chronic diseases, coupled with need for rapid diagnostic techniques, is contributing to the increase in adoption of ISH.
In 2018, the global In Situ Hybridization (ISH) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global In Situ Hybridization (ISH) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Situ Hybridization (ISH) development in United States, Europe and China.
The key players covered in this study
Thermo Fisher Scientific
Leica BiosystemsNussloch GmbH
Bio-Rad Laboratories Inc.
NeoGenomics Laboratories Inc.
Advanced Cell Diagnostics Inc.
Oxford Gene Technology
Market segment by Type, the product can be split into
Kits & Probes
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global In Situ Hybridization (ISH) status, future forecast, growth opportunity, key market and key players.
To present the In Situ Hybridization (ISH) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of In Situ Hybridization (ISH) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.